Asociación entre consumo de antiinflamatorios no esteroideos e insuficiencia cardíaca congestiva

Laredo, Leonor; Rodríguez, Á. Jiménez; Vargas, Emilio; Moreno, A.; Cruz, Alfonso Cavallé; García, Juan de Dios

doi:10.1016/s0025-7753(03)73800-7

Cited by 5 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The present study did not exclude patients with hemodilution anemia. A less common factor was the inadequate use of harmful drugs such as NSAIDs, which render HF patients prone to fluid retention, especially when there is concomitant diuretic use [21][22][23]. It is noteworthy, that a small proportion of patients developed acute HF after emotional stress, a condition that has recently been evaluated in greater depth [24].…”

Section: Discussionmentioning

confidence: 99%

Hospitalization due to acute heart failure. Role of the precipitating factors

Formiga

Chivite

Manito

et al. 2007

International Journal of Cardiology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Hospitalization due to acute heart failure. Role of the precipitating factors

Formiga

Chivite

Manito

et al. 2007

International Journal of Cardiology

View full text Add to dashboard Cite

Cardiovascular Risk of Nonsteroidal Anti‐inflammatory Drugs and Classical and Selective Cyclooxygenase‐2 Inhibitors: A Meta‐analysis of Observational Studies

Arias

González

Fadrique

et al. 2018

The Journal of Clinical Pharma

View full text Add to dashboard Cite

The purpose of this study was to review the published evidence on the clinical use of nonsteroidal anti-inflammatory drugs (NSAIDs) and to assess the cardiovascular risk (CVR) of cyclooxygenase-2 inhibitors (coxibs), excluding aspirin, by means of a meta-analytic procedure. A search was conducted on MEDLINE and EMBASE databases between October 1999 and June 2018. Cohort and case-control studies showing CVR as relative risk (RR), odds ratio, hazard ratio, or incidence rate ratio associated with NSAIDs versus no treatment were selected. We estimated the pooled RR and the 95% confidence interval (CI) for all NSAIDs as a whole and individually. Eighty-seven studies met the inclusion criteria. Overall, NSAIDs were found to be associated with a statistically significantly increased CVR (RR, 1.24 [95%CI, 1.19-1.28]). The risk was slightly higher for coxibs (RR, 1.22 [95%CI, 1.17-1.28]) as compared with nonselective NSAIDs (RR, 1.18 [95%CI, 1.12-1.24]). Data analysis by drug disclosed that rofecoxib (RR, 1.39 [95%CI, 1.31-1.47]), followed by diclofenac (RR, 1.34 [95%CI, 1.26-1.42]) and etoricoxib (RR, 1.27 [95%CI, 1.12-1.43]) were the NSAIDs associated with the highest CVR. Analysis by type of event showed that the highest risk corresponded to vascular events for both coxibs (RR, 2.18 [95%CI, 1.72-2.78]) and nonselective NSAIDs (RR, 2.46 [95%CI, 2.00-3.02]). The meta-analysis results suggest that the use of the marketed coxibs celecoxib and etoricoxib would be related to a statistically significant CVR increase. Etoricoxib CVR could be higher than that for celecoxib. This increment would be similar to classical NSAID CVR.

show abstract

Current awareness: Pharmacoepidemiology and drug safety

2003

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract

Asociación entre consumo de antiinflamatorios no esteroideos e insuficiencia cardíaca congestiva

Cited by 5 publications

References 10 publications

Hospitalization due to acute heart failure. Role of the precipitating factors

Hospitalization due to acute heart failure. Role of the precipitating factors

Cardiovascular Risk of Nonsteroidal Anti‐inflammatory Drugs and Classical and Selective Cyclooxygenase‐2 Inhibitors: A Meta‐analysis of Observational Studies

Current awareness: Pharmacoepidemiology and drug safety

Contact Info

Product

Resources

About